• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非遗传膜工程编程细胞-细胞相互作用。

Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.

机构信息

Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.

Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

Cell Chem Biol. 2018 Aug 16;25(8):931-940. doi: 10.1016/j.chembiol.2018.05.009. Epub 2018 Jun 14.

DOI:10.1016/j.chembiol.2018.05.009
PMID:29909993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6470397/
Abstract

The ability to direct targeted intercellular interactions has the potential to enable and expand the use of cell-based therapies for regenerative medicine, tissue engineering, and immunotherapy. While genetic engineering approaches have proven effective, these techniques are not amenable to all cell types and often yield permanent modifications with potentially long-lasting adverse effects, restricting their application. To circumvent these limitations, there is intense interest in developing non-genetic methods to modify cell membranes with functional groups that will enable the recognition of target cells. While many such techniques have been developed, relatively few have been applied to directing specific cell-cell interactions. This review details these non-genetic membrane engineering approaches-namely, hydrophobic membrane insertion, chemical modification, liposome fusion, metabolic engineering, and enzymatic remodeling-and summarizes their major applications. Based on this analysis, perspective is provided on the ideal features of these systems with an emphasis on the potential for clinical translation.

摘要

靶向细胞间相互作用的能力有可能实现并扩大基于细胞的疗法在再生医学、组织工程和免疫治疗中的应用。虽然基因工程方法已被证明是有效的,但这些技术不适用于所有细胞类型,并且经常产生潜在持久的不利影响的永久性修饰,限制了它们的应用。为了规避这些限制,人们强烈希望开发非遗传方法来用功能基团修饰细胞膜,从而能够识别靶细胞。虽然已经开发了许多这样的技术,但相对较少的技术被应用于指导特定的细胞-细胞相互作用。本综述详细介绍了这些非遗传的膜工程方法,即疏水性膜插入、化学修饰、脂质体融合、代谢工程和酶重塑,并总结了它们的主要应用。基于此分析,提供了对这些系统理想特征的看法,重点是临床转化的潜力。

相似文献

1
Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.通过非遗传膜工程编程细胞-细胞相互作用。
Cell Chem Biol. 2018 Aug 16;25(8):931-940. doi: 10.1016/j.chembiol.2018.05.009. Epub 2018 Jun 14.
2
Engineering reversible cell-cell interactions with chemical biology.运用化学生物学工程化可逆的细胞间相互作用。
Methods Enzymol. 2020;638:167-190. doi: 10.1016/bs.mie.2020.02.019. Epub 2020 Mar 31.
3
Remote control of tissue interactions via engineered photo-switchable cell surfaces.通过工程化光开关细胞表面远程控制组织相互作用
Sci Rep. 2014 Sep 10;4:6313. doi: 10.1038/srep06313.
4
Liposomes in tissue engineering and regenerative medicine.组织工程与再生医学中的脂质体
J R Soc Interface. 2014 Dec 6;11(101):20140459. doi: 10.1098/rsif.2014.0459.
5
Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.工程化具有脂质锚定的假受体的可逆细胞-细胞相互作用。
Bioconjug Chem. 2018 Apr 18;29(4):1291-1301. doi: 10.1021/acs.bioconjchem.8b00058. Epub 2018 Mar 23.
6
[Controlling Cell Dynamics by Cell-surface Modification].通过细胞表面修饰控制细胞动力学
Yakugaku Zasshi. 2021;141(5):661-665. doi: 10.1248/yakushi.20-00219-6.
7
Non-genetic engineering of cells for drug delivery and cell-based therapy.细胞的非遗传工程用于药物输送和基于细胞的治疗。
Adv Drug Deliv Rev. 2015 Aug 30;91:125-40. doi: 10.1016/j.addr.2014.12.003. Epub 2014 Dec 24.
8
Emerging Translation of Regenerative Therapies.再生疗法的新兴翻译
Clin Pharmacol Ther. 2017 Jan;101(1):28-30. doi: 10.1002/cpt.549. Epub 2016 Nov 26.
9
Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.细胞治疗、3D 培养系统和组织工程学在心脏再生中的应用。
Adv Drug Deliv Rev. 2014 Apr;69-70:254-69. doi: 10.1016/j.addr.2013.12.004. Epub 2013 Dec 27.
10
Cell surface engineering and application in cell delivery to heart diseases.细胞表面工程及其在心脏病细胞递送中的应用。
J Biol Eng. 2018 Dec 4;12:28. doi: 10.1186/s13036-018-0123-6. eCollection 2018.

引用本文的文献

1
Cell-Membrane-Anchored DNA Nanoplatform for Programming Cellular Interactions.用于编程细胞相互作用的细胞膜锚定DNA纳米平台。
Methods Mol Biol. 2025;2901:117-130. doi: 10.1007/978-1-0716-4394-5_9.
2
Lipid-Directed Covalent Labeling of Plasma Membranes for Long-Term Imaging, Barcoding and Manipulation of Cells.用于细胞长期成像、条形码标记和操作的质膜脂质定向共价标记
JACS Au. 2025 Feb 12;5(2):922-936. doi: 10.1021/jacsau.4c01134. eCollection 2025 Feb 24.
3
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment.过继性嵌合抗原受体(CAR)免疫细胞免疫疗法与多模式肿瘤治疗方法协同结合的进展。
Bioact Mater. 2024 Sep 10;42:379-403. doi: 10.1016/j.bioactmat.2024.08.046. eCollection 2024 Dec.
4
Biomaterials for extrusion-based bioprinting and biomedical applications.用于基于挤出的生物打印和生物医学应用的生物材料。
Front Bioeng Biotechnol. 2024 Jun 21;12:1393641. doi: 10.3389/fbioe.2024.1393641. eCollection 2024.
5
An Enzyme-Responsive Self-Immolative Recognition Marker for Manipulating Cell-Cell Interactions.一种用于操纵细胞间相互作用的酶响应自毁识别标记物。
Adv Sci (Weinh). 2024 Sep;11(36):e2402278. doi: 10.1002/advs.202402278. Epub 2024 Jul 2.
6
Cell-drug conjugates.细胞药物偶联物。
Nat Biomed Eng. 2024 Nov;8(11):1347-1365. doi: 10.1038/s41551-024-01230-6. Epub 2024 Jul 1.
7
Glycan Modifications as Regulators of Stem Cell Fate.聚糖修饰作为干细胞命运的调节因子
Biology (Basel). 2024 Jan 26;13(2):76. doi: 10.3390/biology13020076.
8
Advancing cell surface modification in mammalian cells with synthetic molecules.利用合成分子推进哺乳动物细胞的细胞表面修饰
Chem Sci. 2023 Nov 10;14(46):13325-13345. doi: 10.1039/d3sc04597h. eCollection 2023 Nov 29.
9
Cell Surface Engineering Tools for Programming Living Assemblies.细胞表面工程工具用于编程活体组装。
Adv Sci (Weinh). 2023 Dec;10(34):e2304040. doi: 10.1002/advs.202304040. Epub 2023 Oct 12.
10
Reversible photoregulation of cell-cell adhesions with opto-E-cadherin.光控 E-钙黏蛋白可逆调控细胞间黏附
Nat Commun. 2023 Oct 9;14(1):6292. doi: 10.1038/s41467-023-41932-0.

本文引用的文献

1
FDA approves first topical gene therapy.美国食品药品监督管理局批准首例局部基因疗法。
Nat Rev Drug Discov. 2023 Jul;22(7):527. doi: 10.1038/d41573-023-00095-9.
2
Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.工程化具有脂质锚定的假受体的可逆细胞-细胞相互作用。
Bioconjug Chem. 2018 Apr 18;29(4):1291-1301. doi: 10.1021/acs.bioconjchem.8b00058. Epub 2018 Mar 23.
3
A bulky glycocalyx fosters metastasis formation by promoting G1 cell cycle progression.大体积的糖萼通过促进 G1 细胞周期进程促进转移形成。
Elife. 2017 Dec 21;6:e25752. doi: 10.7554/eLife.25752.
4
The Promise and Challenges of CAR-T Gene Therapy.嵌合抗原受体T细胞(CAR-T)基因疗法的前景与挑战
JAMA. 2017 Dec 12;318(22):2167-2169. doi: 10.1001/jama.2017.15605.
5
Cell-Surface Glyco-Engineering by Exogenous Enzymatic Transfer Using a Bifunctional CMP-Neu5Ac Derivative.通过使用双功能 CMP-Neu5Ac 衍生物的外源酶转移进行细胞表面糖基工程化。
J Am Chem Soc. 2017 Sep 27;139(38):13342-13348. doi: 10.1021/jacs.7b05358. Epub 2017 Sep 15.
6
Therapeutic T cell engineering.治疗性T细胞工程
Nature. 2017 May 24;545(7655):423-431. doi: 10.1038/nature22395.
7
Scaffold Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue via Cell Surface Engineering.无支架生物正交组装三维心脏组织通过细胞表面工程。
Sci Rep. 2016 Dec 23;6:39806. doi: 10.1038/srep39806.
8
Cell surface-engineering to embed targeting ligands or tracking agents on the cell membrane.通过细胞表面工程将靶向配体或追踪剂嵌入细胞膜。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1042-1047. doi: 10.1016/j.bbrc.2016.11.155. Epub 2016 Nov 29.
9
Spatiotemporal control of cell-cell reversible interactions using molecular engineering.利用分子工程实现细胞间可逆相互作用的时空控制。
Nat Commun. 2016 Oct 6;7:13088. doi: 10.1038/ncomms13088.
10
Toxicity and management in CAR T-cell therapy.嵌合抗原受体 T 细胞疗法的毒性与管理。
Mol Ther Oncolytics. 2016 Apr 20;3:16011. doi: 10.1038/mto.2016.11. eCollection 2016.